Dr. Hossein Amirani, MD

Dr. Amirani practices at Wesley Woodlawn Hospital & ER in Wichita, Kansas.

Dr. Amirani's NPI, 1164493201, was assigned on January 27, 2006. Dr. Amirani graduated from University of Kansas School of Medicine - Kansas City in 1992. Dr. Amirani's Kansas license number on file is 0428505.

Dr. Amirani's primary practice is Wesley Woodlawn Hospital & ER, at 2610 N Woodlawn Blvd, Wichita, KS 67220 in Sedgwick County. The practice phone is (316) 858-2610.

Dr. Amirani's primary practice is Wesley Woodlawn Hospital & ER in Wichita, Kansas. Dr. Amirani is also affiliated with Ascension Via Christi St. Francis. The medical group on file is Ascension Medical Group Via Christi. Dmand AI also links Dr. Amirani to 4 more hospitals, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amirani practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Amirani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Amirani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Amirani's licenses on file in 5 states: Kansas, Arizona, Louisiana, Wisconsin and Iowa.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic embolism thrombosis among the conditions Dr. Amirani treats.

CMS data shows 20,414 Medicare services from Dr. Amirani across 54 procedure codes in 2024, for 2,888 Medicare patients. Medicare paid $864,176 for them.

CMS counts 2,888 Medicare patients who saw Dr. Amirani in 2024. The largest group is 75 to 84, with 1,116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amirani's median patient age at 71, with 49% women.

In 2024, Dr. Amirani wrote 24,968 Medicare Part D claims for 2,514 patients. 75% of them were for generic drugs. CMS names the drug for 24,714 of them, across 82 drugs with 11 or more claims each, at $4,974,441 in total drug cost. In 2023, CMS named 22,016 claims across 72 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Amirani for performance year 2024, reported as part of a group. Dr. Amirani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of coronary angioplasty and stenting by Dr. Amirani, more than 93% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 503 general payments to Dr. Amirani from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Abbott Laboratories paid the most, $6,954.

Dmand AI lists 1 award for Dr. Amirani, most recently CMS Stage 1 EHR in 2013.

Dr. Amirani graduated from University of Kansas School of Medicine - Kansas City in 1992.

Dr. Amirani is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.